Medicinova (MNOV) Total Liabilities (2010 - 2026)
Medicinova (MNOV) posted quarterly Total Liabilities of $4.0 million for Q4 2025, up 19.1% year-over-year from $3.4 million in Q4 2024, and up 11.15% quarter-over-quarter from $3.6 million in Q3 2025.
Medicinova (MNOV) Total Liabilities (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Total Liabilities for 16 consecutive years, with $4.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Liabilities rose 19.1% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $4.0 million (up 19.1% YoY), while the FY2025 annual figure was $4.0 million, up 19.1% from the prior year.
- Total Liabilities climbed to $4.0 million in Q4 2025 per MNOV's latest filing, from $3.6 million in the prior quarter.
- Across five years, Total Liabilities topped out at $5.3 million in Q3 2022 and bottomed at $2.5 million in Q1 2025.
- Historically, Total Liabilities has averaged $3.7 million across 5 years, with a median of $3.7 million in 2021.
- Annual changes were most pronounced in 2021 — Total Liabilities soared 37.47% — and 2023, when it sank 34.4%.
- Medicinova's Total Liabilities stood at $3.7 million in 2021, then grew by 4.92% to $3.9 million in 2022, then slipped by 0.54% to $3.9 million in 2023, then declined by 13.34% to $3.4 million in 2024, then grew by 19.1% to $4.0 million in 2025.
- Business Quant data shows MNOV's Total Liabilities at $4.0 million in Q4 2025, $3.6 million in Q3 2025, and $3.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.16 Mn |
| Dec 31, 2025 | 4.02 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 2.97 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 3.06 Mn |
| Dec 31, 2023 | 3.89 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 3.54 Mn |
| Mar 31, 2023 | 3.41 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 5.29 Mn |
| Jun 30, 2022 | 4.63 Mn |
| Mar 31, 2022 | 3.81 Mn |
| Dec 31, 2021 | 3.73 Mn |
| Sep 30, 2021 | 5.14 Mn |
| Jun 30, 2021 | 4.45 Mn |